Private Equity
108 BioCapital
Log In or Sign up to contact this investor.
Last contacted by {lastContactedBy} on {lastContactDate}.
You last contacted this investor on {lastContactDate}.
{briefsRemaining} of {briefsQuota} Investor Briefs left this billing cycle.
Last contacted by {lastContactedBy} on {lastContactDate}. · {briefsRemaining} of {briefsQuota} Investor Briefs left this billing cycle.
You last contacted this investor on {lastContactDate}. · {briefsRemaining} of {briefsQuota} Investor Briefs left this billing cycle.
About 108 BioCapital
108 BioCapital is a U.S.-based private equity firm focused on growth-stage investments in biotech and medtech companies developing scalable, exit-driven solutions that address high-impact unmet medical needs. We invest in businesses with clear and accelerated regulatory pathways, validated clinical or technical foundations, and a line of sight to meaningful commercial adoption.
At 108 BioCapital, we are dedicated to advancing the frontiers of medical innovation. Our mission is to invest in transformative healthcare solutions that address urgent unmet medical needs, improve patient outcomes, and deliver sustained value to our investors.
The US healthcare and medtech sectors present an extraordinary growth opportunity, with healthcare spending projected to reach 20% of GDP by 2032.
Advances in diagnostics, therapeutic devices, and personalized medicine are reshaping the industry. We seek to partner with visionary entrepreneurs and management teams, leveraging our expertise and network to accelerate growth and maximize impact.
Know your investor before you reach out.
An Investor Brief sums up 108 BioCapital's thesis, recent activity and how to tailor your pitch to them.
Get Investor BriefYour favorites
Save investors as you browse, then compare and message them from one list in My Account.
View your favorites